i was thinking exactly along the same line with fgen lol
"Exactly. FGEN's roxa falls into this category too."
and if for whatever reason i want to go into early on one of these "biotech values", i'll put in a small initial stake and pay up and add slowly as more data and evidence accumulate. i have learned it is a good process to pay for derisking.
that sort of process fits with my psychological profile.
Market Data 
Markets 
AI
